Article Information
History
- May 2, 2021.
Article Versions
- Version 1 (November 4, 2020 - 06:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- David Wyllie, Consultant Microbiologist1,+,
- Hayley E Jones, Senior Lecturer2,
- Ranya Mulchandani, Field Epidemiology Training Programme (UK-FETP) Fellow1,
- Adam Trickey, Senior Research Associate2,
- Sian Taylor-Phillips, Professor3,
- Tim Brooks, Consultant Microbiologist1,
- Andre Charlett, Head of Statistics and Modelling1,
- AE Ades, Professor2,
- EDSAB-HOME investigators,
- Philippa Moore, Consultant Microbiologist5,
- John Boyes, Consultant Microbiologist5,
- Anil Hormis, Consultant Anaesthetist6,
- Neil Todd, Consultant Microbiologist7,
- Ian Reckless, Consultant Physician8,
- Andrew Makin, Vice President, Medical Affairs4 and
- Isabel Oliver, Director National Infection Service1,2
- 1Public Health England
- 2Population Health Sciences, University of Bristol
- 3University of Warwick
- 4Oxford Immunotec Ltd
- 5Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
- 6The Rotherham NHS Foundation Trust, Rotherham, UK
- 7York Teaching Hospital NHS Foundation Trust, York, UK
- 8Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK
- ↵+correspondence:David Wyllie, Public Health England, Forvie Site, Addenbrookes’ Campus, Robinson Way, Cambridge, CB2 0SR., david.wyllie{at}phe.gov.uk
Posted May 02, 2021.
SARS-CoV-2 responsive T cell numbers and anti-Spike IgG levels are both associated with protection from COVID-19: A prospective cohort study in keyworkers
